Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Conditions:   Melanoma;   Hepatocellular Carcinoma;   Non Small Cell Lung Cancer;   Endometrial Cancer Interventions:   Biological: VV1;   Biological: Cemiplimab Sponsors:   Vyriad, Inc.;   Regeneron Pharmaceuticals Not yet recruiting

Source: ClinicalTrials.gov - March 2, 2020 Category: Research Source Type: clinical trials